These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14600511)

  • 1. Monitoring of long-term toxicities of HIV treatments: an international perspective.
    Bisson G; Gross R; Miller V; Weller I; Walker A; Arlett P; Carr A; Evans S; Graham D; Justice A; Kreft-Jais C; Lundgren JD; Munk B; Murray J; Pirmohamed M; Pizzuti D; Szarfman A;
    AIDS; 2003 Nov; 17(17):2407-17. PubMed ID: 14600511
    [No Abstract]   [Full Text] [Related]  

  • 2. Limiting cardiovascular events associated with HIV and antiretroviral therapy.
    Brenner BG; Baril JG
    AIDS; 2017 Nov; 31(18):2551-2553. PubMed ID: 29120901
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the risk of major congenital abnormalities among women on antiretroviral therapy?
    Zash RM; Williams P; Holmes LB
    AIDS; 2018 Jan; 32(3):403-404. PubMed ID: 29309347
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicities of antiretroviral therapy in children.
    Nwaobasi E; Oleske JM
    AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART.
    Lanzafame M; Piacentini D; Lattuada E; Rizzardo S; Chiesi S; Vento S
    Infect Dis (Lond); 2018 Oct; 50(10):788-790. PubMed ID: 29916752
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs.
    Vassilev ZP; Marcus SM
    AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to anti-retroviral drugs.
    Roy MP
    Indian J Med Res; 2016 Feb; 143(2):245. PubMed ID: 27121524
    [No Abstract]   [Full Text] [Related]  

  • 8. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 9. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 14. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 16. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
    Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting JNK to prevent antiretroviral neuropathy.
    Galeotti N
    Oncotarget; 2017 Feb; 8(8):12546-12547. PubMed ID: 28179580
    [No Abstract]   [Full Text] [Related]  

  • 18. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
    Morelle J; Goffin E; Wallemacq P; De Meyer M; Yombi JC; Mourad M; Kanaan N
    Transpl Int; 2010 Oct; 23(10):1065-7. PubMed ID: 20477995
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management.
    Manfredi R
    AIDS; 2003 Oct; 17(15):2253-6. PubMed ID: 14523283
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risks of antiretroviral therapies.
    Mondy K; Tebas P
    Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.